1-6 of 6
Jean-Claude Tardif
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker Study

Hertzel C. Gerstein, Sibylle Hess, Brian Claggett, Kenneth Dickstein, Lars Kober, Aldo P. Maggioni, John J.V. McMurray, Jeffrey L. Probstfield, Matthew C. Riddle, Jean-Claude Tardif, Marc A. Pfeffer
Journal: Diabetes Care
Diabetes Care 2022;45(9):2152–2155
https://doi.org/10.2337/dc22-0453
Published: 11 July 2022
View article titled, Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker Study
Open the PDF for Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker Study in another window
Journal Articles

Glucagon-Like Peptide 1 Receptor Agonists, Carotid Atherosclerosis, and Cardiovascular Outcomes

Guillaume Marquis-Gravel, Jean-Claude Tardif
Journal: Diabetes Care
Diabetes Care 2021;44(6):1252–1253
https://doi.org/10.2337/dci20-0076
Published: 18 June 2021
View article titled, Glucagon-Like Peptide 1 Receptor Agonists, Carotid Atherosclerosis, and Cardiovascular Outcomes
Open the PDF for Glucagon-Like Peptide 1 Receptor Agonists, Carotid Atherosclerosis, and Cardiovascular Outcomes in another window
Journal Articles

Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease

Gregory G. Schwartz, Lawrence A. Leiter, Christie M. Ballantyne, Philip J. Barter, Donald M. Black, David Kallend, Fouzia Laghrissi-Thode, Eran Leitersdorf, John J.V. McMurray, Stephen J. Nicholls, Anders G. Olsson, David Preiss, Prediman K. Shah, Jean-Claude Tardif, John Kittelson
Journal: Diabetes Care
Diabetes Care 2020;43(5):1077–1084
https://doi.org/10.2337/dc19-2204
Published: 06 March 2020
View article titled, Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease
Open the PDF for Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease in another window
Includes: Supplementary data
Journal Articles

Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome

Ilse C. Schrieks, Anna Nozza, Barbara E. Stähli, John B. Buse, Robert R. Henry, Klas Malmberg, Bruce Neal, Stephen J. Nicholls, Lars Rydén, Linda Mellbin, Anders Svensson, Hans Wedel, Arlette Weichert, A. Michael Lincoff, Jean-Claude Tardif, Diederick E. Grobbee, Gregory G. Schwartz
Journal: Diabetes Care
Diabetes Care 2018;41(8):1792–1800
https://doi.org/10.2337/dc18-0158
Published: 14 June 2018
View article titled, Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome
Open the PDF for Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome in another window
Includes: Supplementary data
Journal Articles

Favorable Effects of Insulin Sensitizers Pertinent to Peripheral Arterial Disease in Type 2 Diabetes: Results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial

Andrew D. Althouse, MA, J. Dawn Abbott, MD, Kim Sutton-Tyrrell, DRPH, Alan D. Forker, MD, Manuel S. Lombardero, MS, L. Virginia Buitrón, MD, Ivan Pena-Sing, MD, Jean-Claude Tardif, MD, Maria Mori Brooks, PHD, for the BARI 2D Study Group
Journal: Diabetes Care
Diabetes Care 2013;36(10):3269–3275
https://doi.org/10.2337/dc12-2265
Published: 14 September 2013
View article titled, Favorable Effects of Insulin Sensitizers Pertinent to Peripheral Arterial Disease in Type 2 Diabetes: <subtitle>Results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial</subtitle>
Open the PDF for Favorable Effects of Insulin Sensitizers Pertinent to Peripheral Arterial Disease in Type 2 Diabetes: <subtitle>Results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial</subtitle> in another window
Includes: Supplementary data
Journal Articles

The Effect of Vitamin Therapy on the Progression of Coronary Artery Atherosclerosis Varies by Haptoglobin Type in Postmenopausal Women

Andrew P. Levy, MD, PHD, Paula Friedenberg, MS, Rachel Lotan, PHD, Pamela Ouyang, MD, Mark Tripputi, MS, Lyall Higginson, MD, Frederick R. Cobb, MD, Jean-Claude Tardif, MD, Vera Bittner, MD, Barbara V. Howard, PHD
Journal: Diabetes Care
Diabetes Care 2004;27(4):925–930
https://doi.org/10.2337/diacare.27.4.925
Published: 01 April 2004
View article titled, The Effect of Vitamin Therapy on the Progression of Coronary Artery Atherosclerosis Varies by Haptoglobin Type in Postmenopausal Women
Open the PDF for The Effect of Vitamin Therapy on the Progression of Coronary Artery Atherosclerosis Varies by Haptoglobin Type in Postmenopausal Women in another window